Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

June 22, 2009
Bioniche Provides a Corporate Update

May 28, 2009
Bioniche Represented at House of Commons Sub-Committee on Food Safety

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.

 

News Releases

To receive our news releases directly, please enter your e-mail address here.

Media Coverage

For recent media coverage of Bioniche Life Sciences Inc. click here >>

Latest News

June 22, 2009
Bioniche Provides a Corporate Update more...

May 28, 2009
Bioniche Represented at House of Commons Sub-Committee on Food Safety more...

May 22, 2009
Bioniche Phase III Clinical Trial with Urocidin™ Progressing Well more...

More News

Category: 


Bioniche Key Facts

Founded: 1979

Chairman, President & CEO:
Graeme McRae

TSX stock symbol:
BNC

Fiscal year-end:
June 30

2008 revenues:
C$27.7 million

Headquarters:
Belleville, Ontario

Employees worldwide:
200

Business divisions:
Human Health,
Animal Health,
Food Safety

Focus areas:
Human Health:
cancer, immunomodulation

Animal Health:
reproduction, vaccines, replacement of antibiotics

Food Safety: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health

Top products:

Animal Health:
Folltropin®-V, MAP®-5

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy